Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG - Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030105

Enrollment

Registered

2017-11-24

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery bypass grafting

Interventions

dose of landiolol is not loaded, and increased every 10 minutes from 5 mcl/kg/min,15mcl/kg/min , 25 mcl/kg/min,35mcl/kg/min.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for on-pump beating-heart technique CABG for surgical revascularization with general anesthesia

Exclusion criteria

Exclusion criteria: Patients who can not obtain informed consent Patients judged inappropriate by the physician in charge of this study Patients with atrial fibrillation

Design outcomes

Primary

Measure	Time frame
dose of landiolol and heart rate during on pump beating heart	—

Countries

Japan

Contacts

Public Contactkawashima shingo

Hamamatsu University School of Medicine Department of Anesthesiology and Intensive Care

shingogo@hama-med.ac.jp0534352111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026